10 December | 3:00–4:30 p.m. | ROOM 3

Transatlantic partnerships in 2027: Balancing strategic autonomy and scientific cooperation in health innovation

How can Europe and the United States deepen scientific cooperation while strengthening the capabilities each needs to remain resilient and competitive? This Life Science Diplomacy Alliance forum examines how innovation parks, TTOs, and scaling SMEs can connect regional priorities with shared ambitions in health innovation. Drawing on scientific, commercial, investment and diplomatic perspectives, the discussion will explore access to research, infrastructure and talent; the relationship between openness, trust and reciprocity; and the distribution of benefits and responsibilities between partners. Which forms of cooperation should we prioritise in 2027, and how can they strengthen both our individual capabilities and our capacity to address shared health challenges?

 11 December | 11:00 a.m.–12:30 p.m. | CONFERENCE AREA 2

Global growth, local strength: What makes cross-border collaboration work in 2027?

International partnerships can open access to capital, clinical expertise, and new markets. As the world changes, what makes these partnerships work for the companies, institutions, and regions involved? This Life Science Diplomacy Alliance forum explores how to combine complementary strengths across borders while creating lasting value for each partner. Where should research, validation, and commercial activity take place? How can founders, investors, and public agencies align their interests when their measures of success differ? Looking ahead to 2027, participants will examine how to choose partners, navigate competing expectations, and build collaborations that support international growth while strengthening the ecosystems from which innovation emerges.